BranchOut Food Inc. (BOF) · Oct 22, 2026 · Earnings
Miss — Q3 revenue ~$1.0M vs published consensus ~$1.65M–$1.77M
BranchOut’s earnings update shows a sharp Q3 revenue miss but a potentially transformative Q4 ramp, alongside a new stock offering with unknown dilution.
BranchOut is a growth-stage food company scaling a Peru manufacturing base across branded snacks, private-label products, and industrial ingredients; recent company updates had already highlighted warehouse-club expansion and rising factory utilization.
The reported quarter was a clear miss, not just a timing win. Preliminary Q3 revenue of roughly $1.0 million came in below the published consensus range of about $1.65 million–$1.77 million, even though the company says approximately $420,000 of warehouse-club shipments moved into early October.
| Metric | Filing / reference |
|---|---|
| Q3 2026 revenue | ~$1.0M (preliminary) (Q3 business update) |
| Published Q3 revenue consensus | ~$1.65M–$1.77M (external reference) |
| Q4 2026 revenue outlook | $6M–$7M (Q3 business update) |
| Expected FY2026 revenue | $14M–$15M (Q3 business update) |
| Q4 midpoint annualized run rate | ~$26M (Q3 business update) |
| September production | 55,000 kg (Q3 business update) |
| Q4 production target | 60,000–70,000 kg per month (Q3 business update) |
| Cash operating breakeven | ~$18M annual revenue optimized; ~$21M at recent costs (Q3 business update) |
The forward business picture is materially better than the quarter itself. Management is pointing to $6 million–$7 million of Q4 revenue, a new warehouse-club replenishment program, and expanded blueberry, strawberry, and banana ingredient commitments. The important change is not merely a large quarter; it is the claim that recurring retail replenishment and ingredients embedded in customer formulations could reduce the historical dependence on sporadic purchase orders. The direction was partly known from earlier retail and production updates, so the filing adds more detail and scale than a wholly new commercial breakthrough.
The company is approaching, but has not clearly crossed, its profitability threshold. September production reached 55,000 kilograms, while Q4 targets of 60,000–70,000 kilograms are above the company’s stated recent-cost breakeven level of roughly 55,000 kilograms per month. 〔0〕 That supports the margin-improvement story, but the filing gives no actual Q3 gross margin, cash balance, or evidence that breakeven has been sustained.
The stock offering adds financing capacity but also an unresolved dilution cost. BranchOut has commenced an underwritten public offering of common stock, with a possible 15% over-allotment option, but it has not disclosed the number of shares, offering price, gross proceeds, or intended use of funds. That makes the financing strategically relevant for inventory, production, and growth execution, while preventing investors from measuring the ownership dilution or whether the capital materially extends funding capacity.
Bottom line: This is a mixed update: Q3 materially missed expectations, but the booked-order and recurring-revenue setup points to a much stronger Q4 and a potentially more predictable 2027 business. The new equity offering is the immediate complication because its size and dilution remain unknown.
November dollar-channel retail test
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!